| scholarly article | Q13442814 |
| P2093 | author name string | Rickson R Pereira | |
| Prema K Varthakavi | |||
| Sangeeta T Amladi | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies | Q29614505 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. | Q34558876 | ||
| The comorbid state of psoriasis patients in a university dermatology practice. | Q36374594 | ||
| Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes | Q39289703 | ||
| Cutoff Values for Normal Anthropometric Variables in Asian Indian Adults | Q39648049 | ||
| Metabolic syndrome in urban Asian Indian adults--a population study using modified ATP III criteria | Q39649928 | ||
| Psoriasis and occlusive vascular disease | Q41043440 | ||
| A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome | Q42460037 | ||
| Lipid profile, insulin secretion, and insulin sensitivity in psoriasis | Q44081933 | ||
| The lipid profile in psoriasis: a controlled study | Q46933619 | ||
| Serum lipid level in Iranian patients with psoriasis. | Q51469568 | ||
| Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis. | Q51498390 | ||
| Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis? | Q51593823 | ||
| Diabetic Status in Psoriasis. | Q51662473 | ||
| The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. | Q53014491 | ||
| Disease concomitance in psoriasis. | Q54171239 | ||
| Prevalence of cardiovascular risk factors in patients with psoriasis | Q60711908 | ||
| Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis | Q79190342 | ||
| Comorbidities in psoriasis | Q79899208 | ||
| Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study | Q80439172 | ||
| Psoriasis and diabetes: a population-based cross-sectional study | Q80846541 | ||
| Psoriasis and Diabetes Millitus | Q95482121 | ||
| Blood Sugar and Serum Cholesterol Levels in Psoriasis | Q95484507 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| P304 | page(s) | 520-526 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Indian Journal of Dermatology | Q15710013 |
| P1476 | title | A study of the prevalence of diabetes, insulin resistance, lipid abnormalities, and cardiovascular risk factors in patients with chronic plaque psoriasis | |
| P478 | volume | 56 |
| Q42367098 | Association of Metabolic Syndrome in Chronic Plaque Psoriasis Patients and their Correlation with Disease Severity, Duration and Age: A Case Control Study from Western Maharashtra |
| Q35954321 | Associations between cardiovascular risk factors and psoriasis in Iran |
| Q35028089 | Clinico-biochemical correlation between psoriasis and insulin resistance |
| Q58447307 | Disturbed postprandial glucose metabolism and gut hormone responses in non-diabetic patients with psoriasis |
| Q93050469 | Evaluation of serum lipid, lipoprotein, and apolipoprotein levels in psoriatic patients: a systematic review and meta-analysis of case-control studies |
| Q53843026 | Insulin resistance and skin diseases. |
| Q37054337 | Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients |
| Q37734265 | Metabolic Syndrome in Psoriasis among Urban South Indians: A Case Control Study Using SAM-NCEP Criteria |
| Q36708804 | Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control Study |
| Q36048427 | Prevalence of cardiovascular disease risk factors, and metabolic syndrome and its components in patients with psoriasis aged 30 to 49 years |
| Q40419030 | Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring |
| Q90398387 | Risk and severity of psoriasis vulgaris in relation to angiotensin II type 1 receptor gene polymorphism and metabolic syndrome |
| Q36124545 | Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis |
| Q39620045 | Subclinical cardiovascular disease and it's improvement after long-term TNF-α inhibitor therapy in severe psoriatic patients |
| Q50654661 | ULK1 prevents cardiac dysfunction in obesity through autophagy-meditated regulation of lipid metabolism. |
Search more.